These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27837519)

  • 21. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Efflux Pumps and Fatty Acid Activator One Genes in Azole Resistant Candida Glabrata Isolated From Immunocompromised Patients.
    Farahyar S; Zaini F; Kordbacheh P; Rezaie S; Falahati M; Safara M; Raoofian R; Hatami K; Mohebbi M; Heidari M
    Acta Med Iran; 2016 Jul; 54(7):458-64. PubMed ID: 27424018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France.
    Choukri F; Botterel F; Sitterlé E; Bassinet L; Foulet F; Guillot J; Costa JM; Fauchet N; Dannaoui E
    Med Mycol; 2015 Aug; 53(6):593-6. PubMed ID: 26026171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostics and susceptibility testing in Aspergillus.
    Bernal-Martínez L; Alastruey-Izquierdo A; Cuenca-Estrella M
    Future Microbiol; 2016; 11(2):315-28. PubMed ID: 26848512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
    Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low rate of azole resistance in cases of avian aspergillosis in Germany.
    Barber AE; Scheufen S; Walther G; Kurzai O; Schmidt V
    Med Mycol; 2020 Nov; 58(8):1187-1190. PubMed ID: 32497229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW
    Drug Resist Updat; 2013 Dec; 16(6):81-95. PubMed ID: 24618110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
    Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
    J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular assay to detect nosocomial fungal infections in intensive care units.
    Badiee P; Alborzi A; Joukar M
    Eur J Intern Med; 2011 Dec; 22(6):611-5. PubMed ID: 22075290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Causative Agents of Aspergillosis Including Cryptic Aspergillus Species and A. fumigatus].
    Toyotome T
    Med Mycol J; 2016; 57(4):J149-J154. PubMed ID: 27904060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.
    Chen Y; Lu Z; Zhao J; Zou Z; Gong Y; Qu F; Bao Z; Qiu G; Song M; Zhang Q; Liu L; Hu M; Han X; Tian S; Zhao J; Chen F; Zhang C; Sun Y; Verweij PE; Huang L; Han L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5878-84. PubMed ID: 27431231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
    Hamprecht A; Buchheidt D; Vehreschild JJ; Cornely OA; Spiess B; Plum G; Halbsguth TV; Kutsch N; Stippel D; Kahl P; Persigehl T; Steinbach A; Bos B; Hallek M; Vehreschild MJ
    Euro Surveill; 2012 Sep; 17(36):20262. PubMed ID: 22971327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species.
    Butts A; Reitler P; Ge W; Fortwendel JR; Palmer GE
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The yeast, the antifungal, and the wardrobe: a journey into antifungal resistance mechanisms of
    Oliveira JS; Pereira VS; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Brilhante RSN; Rocha MFG
    Can J Microbiol; 2020 Jun; 66(6):377-388. PubMed ID: 32319304
    [No Abstract]   [Full Text] [Related]  

  • 37. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
    Verweij PE; Ananda-Rajah M; Andes D; Arendrup MC; Brüggemann RJ; Chowdhary A; Cornely OA; Denning DW; Groll AH; Izumikawa K; Kullberg BJ; Lagrou K; Maertens J; Meis JF; Newton P; Page I; Seyedmousavi S; Sheppard DC; Viscoli C; Warris A; Donnelly JP
    Drug Resist Updat; 2015; 21-22():30-40. PubMed ID: 26282594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.
    Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interspecies discrimination of A. fumigatus and siblings A. lentulus and A. felis of the Aspergillus section Fumigati using the AsperGenius
    Chong GM; Vonk AG; Meis JF; Dingemans GJ; Houbraken J; Hagen F; Gaajetaan GR; van Tegelen DW; Simons GF; Rijnders BJ
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):247-252. PubMed ID: 28007314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
    J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.